Atenolol Versus Losartan in the Prevention of Progressive Dilation of the Aorta in Marfan Syndrome
Status:
Unknown status
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of Losartan versus Atenolol in the
progression of aortic dilatation in patients with Marfan syndrome.